Delivery Order SPE2DB20D3101-SPE2DB24FRQS2
Award Date
7/23/24
Potential Completion Date
7/24/24
Potential Value
$5.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication, at a firm fixed price of $2,295.47. The contract has an ultimate completion date of April 11, 2025 and is not set aside for any special type of business. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $2,853.96 contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a brand-name insulin medication, to support military treatment programs and facilities. The contract has a completion date of February 6, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes treatment medication, at a firm fixed price of $2,227.55. The contract has an ultimate completion date of April 23, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract has a ceiling value of $4,263.56 and an ultimate completion date of September 30, 2024. The contract is a firm-fixed price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of a larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of 4564313251 NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract has a firm-fixed price of $1,634.66 and an ultimate completion date of April 18, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,269.26, is for the procurement of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract has a final completion date of February 27, 2025 and uses a firm fixed price pricing type. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,199.67, is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract has a firm fixed price pricing type and a period of performance through March 13, 2025. This award is not associated with a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,372.92, is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract has an ultimate completion date of March 24, 2025 and is a firm fixed-price contract. There is no set-aside designation indicated for this award. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,226.31, is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract has an ultimate completion date of March 3, 2025 and is a firm fixed-price delivery order. AmerisourceBergen is the prime contractor, and the contract is not designated as a set-aside....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, with a ceiling value of $3,351.77. The contract is a firm fixed-price, non-set-aside contract with an ultimate completion date of May 20, 2025. Amerisourcebergen Drug Corp holds a...